Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for CUBIST PHARMS INC

    Client Virtual Booth

    CUBIST PHARMS INC

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Formulations

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    CUBIST PHARMS INC
    Switzerland Flag
    Country
    Country
    Switzerland
    Address
    Address
    Thurgauerstrasse 36/38, 8050 Zurich
    Telephone
    Telephone
    +41 58 433 43 00
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    --
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Merck scores a new Zerbaxa indication
    Merck scores a new Zerbaxa indication

    https://www.fiercepharma.com/pharma/merck-scores-zerbaxa-label-expansion-years-after-cubist-buyout

    Eric Sagonowsky FIERCE PHARMA
    05 Jun 2019
    Share Share
    Merck set to seek EU, US approval of Zerbaxa for pneumonia
    Merck set to seek EU, US approval of Zerbaxa for pneumonia

    https://www.firstwordpharma.com/node/1590308

    Matthew Dennis FIRST WORD PHARMA
    12 Sep 2018
    Share Share
    Merck heralds a rare Big Pharma success for antibiotic PhIII, but..
    Merck heralds a rare Big Pharma success for antibiotic PhIII, but..

    https://endpts.com/merck-heralds-a-rare-big-pharma-success-for-antibiotic-phiii-but-its-also-a-cautionary-tale-about-the-market/

    John Carroll ENDPTS
    11 Sep 2018
    Share Share
    Kaleido Biosciences Emerges From Stealth Mode With $65 Million
    Kaleido Biosciences Emerges From Stealth Mode With $65 Million

    http://www.biospace.com/News/kaleido-biosciences-emerges-from-stealth-mode-with/469546/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

    Mark Terry BIOSPACE
    18 Sep 2017
    Share Share
    Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers
    Generics set to undercut blockbusters from Merck, Novartis and Bristol-Myers

    http://www.fiercepharma.com/pharma/generics-set-to-undercut-blockbusters-from-merck-novartis-bms-2017

    Eric Sagonowsky FIERCE PHARMA
    18 Jan 2017
    Share Share
    Amplyx Pharmaceuticals Appoints Ciara Kennedy, Ph.D., as President and CEO
    Amplyx Pharmaceuticals Appoints Ciara Kennedy, Ph.D., as President and CEO

    http://www.prnewswire.com/news-releases/amplyx-pharmaceuticals-appoints-ciara-kennedy-phd-as-president-and-chief-executive-officer-300384074.html

    PR NEWSWIRE
    05 Jan 2017
    Share Share
    Magenta Bags $48.5M & Will be Helmed by Former GlaxoSmithKline R&D Head
    Magenta Bags $48.5M & Will be Helmed by Former GlaxoSmithKline R&D Head

    http://www.biospace.com/News/cambridge-upstart-magenta-therapeutics-bags-48-5/439375/source=TopBreaking?intcid=homepage-seekernewssection-tabtopbreakingnews

    Alex Keown BIOSPACE
    17 Nov 2016
    Share Share
    Merck lines up for a quick approval with its C. diff therapy
    Merck lines up for a quick approval with its C. diff therapy

    http://www.fiercebiotech.com/story/merck-lines-quick-approval-its-c-diff-therapy/2016-01-27

    Damian Garde FIERCE BIOTECH
    28 Jan 2016
    Share Share
    Behind-the-scenes at Cards Against Biotechnology, Cubist's snarky 'last hurrah'
    Behind-the-scenes at Cards Against Biotechnology, Cubist's snarky 'last hurrah'

    http://www.fiercepharmamarketing.com/story/behind-scenes-look-cards-against-biotechnology-cubists-snarky-last-hurrah/2015-11-30

    Emily Wasserman FIERCE PHARMA MARKETING
    30 Nov 2015
    Share Share
    Teva wagers up to $410M on Heptares' migraine program
    Teva wagers up to $410M on Heptares' migraine program

    http://www.fiercebiotech.com/story/teva-wagers-410m-heptares-migraine-program/2015-11-25

    Damian Garde FIERCE BIOTECH
    26 Nov 2015
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search